Loading...
Market
How will Novo Nordisk's stock price change by September 30, 2024, in response to the reprimand?
3
Resolution / Starting Odds
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Stock market data from financial news sources like Bloomberg or Reuters
Story
Novo Nordisk Reprimanded by UK Regulators for £7.8 Million Undisclosed Payments
Jul 5, 2024, 02:16 PM
Danish drugmaker Novo Nordisk has been reprimanded by UK regulators for failing to disclose fees and expenses paid to individuals and organizations in the healthcare sector in Britain. The undisclosed payments amount to approximately £7.8 million.
View original story
Similar markets
Increase by more than 5% • 25%
Increase by 0-5% • 25%
Decrease by 0-5% • 25%
Decrease by more than 5% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Below $200 • 25%
$200 - $250 • 25%
$250 - $300 • 25%
Above $300 • 25%
Increase by more than 5% • 25%
Change within +/- 5% • 25%
Decrease by 5-10% • 25%
Decrease by more than 10% • 25%
Below $100 • 25%
$100 to $125 • 25%
$126 to $150 • 25%
Above $150 • 25%